APA aipamena

Langdon, C. G., Held, M. A., Platt, J. T., Meeth, K., Iyidogan, P., Mamillapalli, R., . . . Stern, D. F. (2015). The Broad Spectrum Receptor Tyrosine Kinase Inhibitor Dovitinib Suppresses Growth of BRAF Mutant Melanoma Cells in Combination with Other Signaling Pathway Inhibitors. Pigment Cell Melanoma Res.

Chicago Style aipamena

Langdon, Casey G., et al. "The Broad Spectrum Receptor Tyrosine Kinase Inhibitor Dovitinib Suppresses Growth of BRAF Mutant Melanoma Cells in Combination With Other Signaling Pathway Inhibitors." Pigment Cell Melanoma Res 2015.

MLA aipamena

Langdon, Casey G., et al. "The Broad Spectrum Receptor Tyrosine Kinase Inhibitor Dovitinib Suppresses Growth of BRAF Mutant Melanoma Cells in Combination With Other Signaling Pathway Inhibitors." Pigment Cell Melanoma Res 2015.